HCA Healthcare (NYSE:HCA) Given New $395.00 Price Target at Wells Fargo & Company

HCA Healthcare (NYSE:HCA) had its price target raised by Wells Fargo & Company from $365.00 to $395.00 in a research note released on Tuesday morning, Benzinga reports. They currently have an equal weight rating on the stock.

Several other research analysts have also recently commented on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. KeyCorp assumed coverage on shares of HCA Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $475.00 price objective on the stock. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Oppenheimer lifted their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $377.17.

HCA Healthcare Trading Down 8.8 %

NYSE HCA opened at $363.75 on Tuesday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare has a 52 week low of $220.55 and a 52 week high of $417.14. The stock has a market capitalization of $95.27 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 1.44 and a beta of 1.67. The stock’s 50 day moving average price is $395.26 and its two-hundred day moving average price is $352.63.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $4.29 EPS. As a group, analysts anticipate that HCA Healthcare will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. HCA Healthcare’s payout ratio is 13.16%.

Insiders Place Their Bets

In related news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock worth $5,747,945 in the last 90 days. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Oak Harvest Investment Services bought a new position in shares of HCA Healthcare in the 3rd quarter valued at $2,875,000. Adams Diversified Equity Fund Inc. bought a new position in HCA Healthcare in the third quarter valued at about $12,396,000. Hedeker Wealth LLC grew its holdings in shares of HCA Healthcare by 3.0% during the third quarter. Hedeker Wealth LLC now owns 11,263 shares of the company’s stock worth $4,577,000 after purchasing an additional 325 shares during the last quarter. PBMares Wealth Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $222,000. Finally, Integrated Advisors Network LLC increased its position in HCA Healthcare by 0.6% in the 3rd quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after acquiring an additional 31 shares during the period. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.